Beijing Medical and Health Industry Investment Fund

The Beijing Medical and Health Industry Investment Fund is a government-backed investment fund established to support the development of China's healthcare and medical industries. It focuses on investing in innovative pharmaceuticals, high-end medical devices, and basic research platforms, aiming to enhance clinical applications and promote technological advancements in the sector. The fund collaborates with national teams to transform scientific research into tangible outcomes, providing support in areas such as R&D, clinical assistance, and corporate governance for innovative enterprises at various stages of their lifecycle.

The fund's investment strategy encompasses early-stage, growth, and late-stage investments, with a typical investment size ranging from 5 million to 50 million USD. It primarily targets companies within China, particularly those involved in biotechnology, pharmaceuticals, medical devices, healthcare, and therapeutics. By leveraging its substantial industrial background and resources in scientific and technological innovation, the fund aims to foster the growth of health products and services with technological barriers that can truly enhance clinical application scenarios.

Since its inception, the Beijing Medical and Health Industry Investment Fund has been actively investing in and fostering health products and services with technological barriers that can truly enhance clinical application scenarios. It has invested in a number of innovative businesses, including CH Biomedical Medical and Baheal Pharma. The fund's commitment to supporting the healthcare sector aligns with Beijing's broader efforts to become an international sci-tech innovation center, as evidenced by the establishment of multibillion funds to support industries such as medicine and healthcare, artificial intelligence, robotics, and information technology.